BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 3022436)

  • 1. Effects of platelet antagonists on the reduction in platelet density caused by microbubbles in vitro.
    Thorsen T; Ovstedal T; Vereide A; Holmsen H
    Undersea Biomed Res; 1986 Sep; 13(3):289-303. PubMed ID: 3022436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for production of N2 microbubbles in platelet-rich plasma in an aggregometer-like apparatus, and effect on the platelet density in vitro.
    Thorsen T; Brubakk A; Ovstedal T; Farstad M; Holmsen H
    Undersea Biomed Res; 1986 Sep; 13(3):271-88. PubMed ID: 3775967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of platelet aggregation in vitro by microbubbles of nitrogen.
    Thorsen T; Lie RT; Holmsen H
    Undersea Biomed Res; 1989 Nov; 16(6):453-64. PubMed ID: 2603242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bubble-induced aggregation of platelets: effects of gas species, proteins, and decompression.
    Thorsen T; Klausen H; Lie RT; Holmsen H
    Undersea Hyperb Med; 1993 Jun; 20(2):101-19. PubMed ID: 8392414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC; Liao CH; Chang YW; Liou JT; Day YJ
    Biochem Pharmacol; 2009 Apr; 77(8):1364-73. PubMed ID: 19426675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC; Huang WH; Shiau CY; Lee AR; Chou TC
    Eur J Pharmacol; 2006 Feb; 532(1-2):32-7. PubMed ID: 16457809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transmission and scanning electron microscopy of N2 microbubble-activated human platelets in vitro.
    Thorsen T; Dalen H; Bjerkvig R; Holmsen H
    Undersea Biomed Res; 1987 Jan; 14(1):45-58. PubMed ID: 3810992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antimycin and 2-deoxyglucose on adenine nucleotides in human platelets. Role of metabolic adenosine triphosphate in primary aggregation, secondary aggregation and shape change of platetets.
    Holmsen H; Setkowsky CA; Day HJ
    Biochem J; 1974 Nov; 144(2):385-96. PubMed ID: 4462589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of cAMP phosphodiesterase inhibitors on ADP-induced shape change, cAMP and nucleoside diphosphokinase activity of rabbit platelets.
    Lam SC; Guccione MA; Packham MA; Mustard JF
    Thromb Haemost; 1982 Apr; 47(2):90-5. PubMed ID: 6285543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term exposure of platelets to glucose impairs inhibition of platelet aggregation by cyclooxygenase inhibitors.
    Kobzar G; Mardla V; Samel N
    Platelets; 2011; 22(5):338-44. PubMed ID: 21557683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
    Maurice DH; Haslam RJ
    Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microbubble-induced phospholipase C activation does not correlate with platelet aggregation.
    Malmgren R; Thorsen T; Nordvik A; Holmsen H
    Thromb Haemost; 1993 Apr; 69(4):394-6. PubMed ID: 8388581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of sodium periodate on platelet functions.
    Cazenave JP; Reimers HJ; Kinlough-Rathbone RL; Packham MA; Mustard JF
    Lab Invest; 1976 May; 34(5):471-81. PubMed ID: 178961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbubble-induced serotonin secretion in human platelets.
    Malmgren R; Thorsen T; Lie RT; Holmsen H
    Thromb Haemost; 1991 Apr; 65(4):399-402. PubMed ID: 2057922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of U46619 induced human platelet aggregation by aspirin.
    Kim JM; Koo YK; Jin J; Lee YY; Park S; Yun-Choi HS
    Platelets; 2009 Mar; 20(2):111-9. PubMed ID: 19235053
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of DK-002, a synthesized (6aS,cis)-9,10-Dimethoxy-7,11b-dihydro-indeno[2,1-c]chromene-3,6a-diol, on platelet activity.
    Lee KS; Khil LY; Chae SH; Kim D; Lee BH; Hwang GS; Moon CH; Chang TS; Moon CK
    Life Sci; 2006 Feb; 78(10):1091-7. PubMed ID: 16153663
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rat platelet aggregation by ATP. Aggregometrical and ultrastructural comparison with aggregations induced by ADP and collagen.
    Ts'ao C
    Am J Pathol; 1976 Dec; 85(3):581-94. PubMed ID: 998732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of mitomycin C on platelet aggregation and adenosine 3',5'-monophosphate metabolism.
    Hashimoto S; Shibata S; Kobayashi B
    Thromb Haemost; 1978 Feb; 39(1):177-85. PubMed ID: 205972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M; Welzel D; Wolf H; Honey A; Kakkar VV
    Arzneimittelforschung; 1987 Jun; 37(6):669-74. PubMed ID: 2822055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.